Plenty of pills: Polypharmacy prevails in patients of a Danish anticoagulant clinic

European Journal of Clinical Pharmacology

Volumn 67, Issue 11, 2011, Pages 1169-1174

  Skov, Jane ^a   Bladbjerg, Else Marie ^a   Sidelmann, Johannes ^a   Vamosi, Marianne ^a   Jespersen, Jørgen ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b University of Southern Denmark ^*  (Denmark)

Author keywords

Adverse drug events; Alternative medicine; Anticoagulant treatment; Polypharmacy; Vitamin K antagonists

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PHARMACY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG POTENTIATION; DRUG SURVEILLANCE PROGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYPHARMACY; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT DURATION;

AGED; AMBULATORY CARE FACILITIES; ANTICOAGULANTS; ATRIAL FIBRILLATION; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; DENMARK; DRUG INTERACTIONS; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; POLYPHARMACY; QUESTIONNAIRES; VITAMIN K;

EID: 80054741465     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1045-0     Document Type: Article

References (22)

1. BF Gage C van Walraven L Pearce RG Hart PJ Koudstaal BS Boode P Petersen 2004 Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin Circulation 110 2287 2292 15477396 10.1161/01.CIR.0000145172.55640.93 1:CAS:528:DC%2BD2cXosVSlsLc%3D (Pubitemid 39407328)
2. AJ Camm P Kirchhof GY Lip U Schotten I Savelieva S Ernst IC Van Gelder N Al-Attar G Hindricks B Prendergast H Heidbuchel O Alfieri A Angelini D Atar P Colonna CR De SJ De A Goette B Gorenek M Heldal SH Hohloser P Kolh JY Le Heuzey P Ponikowski FH Rutten 2010 Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2369 2429 20802247 10.1093/eurheartj/ehq278
3. N Oake DA Fergusson AJ Forster C van Walraven 2007 Frequency of adverse events in patients with poor anticoagulation: a meta-analysis Can Med Assoc J 176 1589 1594 10.1503/cmaj.061523 (Pubitemid 46868607)
4. AM Njaastad U Abildgaard JF Lassen 2006 Gains and losses of warfarin therapy as performed in an anticoagulation clinic J Intern Med 259 296 304 16476107 10.1111/j.1365-2796.2005.01605.x 1:CAS:528:DC%2BD28XjslCmtbs%3D
5. C Manotti M Moia G Palareti V Pengo L Ria AG Dettori 2001 Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated PRogram for Oral Anticoagulant Treatment) Haematologica 86 1060 1070 11602412 1:STN:280:DC%2BD3MrlsFOgsw%3D%3D (Pubitemid 33031872)
6. L Poller CR Shiach PK MacCallum AM Johansen AM Munster A Magalhaes J Jespersen 1998 Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation Lancet 352 1505 1509 9820298 10.1016/S0140-6736(98)04147-6 1:CAS:528:DyaK1cXnsFeltbk%3D (Pubitemid 28512926)
7. L Poller M Keown S Ibrahim G Lowe M Moia AG Turpie C Roberts AM van den Besselaar FJ van der Meer A Tripodi G Palareti C Shiach S Bryan M Samama M Burgess-Wilson A Heagerty P Maccallum D Wright J Jespersen 2008 An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage J Thromb Haemost 6 935 943 18489430 10.1111/j.1538-7836. 2008.02959.x 1:CAS:528:DC%2BD1cXotFaqtLg%3D (Pubitemid 351689914)
8. JA Delaney L Opatrny JM Brophy S Suissa 2007 Drug-drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding Can Med Assoc J 177 347 351 10.1503/cmaj.070186 (Pubitemid 47339530)
9. RA Sansone LA Sansone 2009 Warfarin and Antidepressants: Happiness without Hemorrhaging Psychiatry (Edgmont) 6 24 29
10. A Fugh-Berman E Ernst 2001 Herb-drug interactions: review and assessment of report reliability Br J Clin Pharmacol 52 587 595 11736868 10.1046/j.0306-5251.2001.01469.x 1:STN:280:DC%2BD3MnpsF2hug%3D%3D
11. NA Ramsay MW Kenny G Davies JP Patel 2005 Complimentary and alternative medicine use among patients starting warfarin Br J Haematol 130 777 780 16115136 10.1111/j.1365-2141.2005.05689.x (Pubitemid 43906651)
12. AM Holbrook JA Pereira R Labiris H McDonald JD Douketis M Crowther PS Wells 2005 Systematic overview of warfarin and its drug and food interactions Arch Intern Med 165 1095 1106 15911722 10.1001/archinte.165.10.1095 1:CAS:528:DC%2BD2MXlsFaju78%3D (Pubitemid 40720733)
13. DN Juurlink 2007 Drug interactions with warfarin: what clinicians need to know Can Med Assoc J 177 369 371 10.1503/cmaj.070946 (Pubitemid 47339534)
14. HH Thijssen BA Soute LM Vervoort JG Claessens 2004 Paracetamol (acetaminophen) warfarin interaction: NAPQI, the toxic metabolite of paracetamol, is an inhibitor of enzymes in the vitamin K cycle Thromb Haemost 92 797 802 15467911 1:CAS:528:DC%2BD2cXovVOlsbg%3D (Pubitemid 39386707)
15. L Poller M Keown S Ibrahim G Lowe M Moia AG Turpie C Roberts AM van den Besselaar FJ van der Meer A Tripodi G Palareti C Shiach S Bryan M Samama M Burgess-Wilson A Heagerty P Maccallum D Wright J Jespersen 2009 A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program Thromb Haemost 101 487 494 19277410 1:CAS:528:DC%2BD1MXjslSnt7c%3D
16. C Gasse J Hollowell CR Meier WE Haefeli 2005 Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin Thromb Haemost 94 537 543 16268469 1:CAS:528:DC%2BD2MXhtVaqur3L (Pubitemid 41300849)
17. K Schaefer H Maerkedahl HO Birk LO Henriksen 2010 Polypharmacy in general practice Dan Med Bull 57 A4165 20591340
18. PA Atkin PC Veitch EM Veitch SJ Ogle 1999 The epidemiology of serious adverse drug reactions among the elderly Drugs Aging 14 141 152 10084366 10.2165/00002512-199914020-00005 1:STN:280:DyaK1M7otFymtQ%3D%3D (Pubitemid 29086114)
19. G Onder C Pedone F Landi M Cesari VC Della R Bernabei G Gambassi 2002 Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA) J Am Geriatr Soc 50 1962 1968 12473007 10.1046/j.1532-5415.2002.50607.x (Pubitemid 35462441)
20. TE Klein RB Altman N Eriksson BF Gage SE Kimmel MT Lee NA Limdi D Page DM Roden MJ Wagner MD Caldwell JA Johnson 2009 Estimation of the warfarin dose with clinical and pharmacogenetic data N Engl J Med 360 753 764 19228618 10.1056/NEJMoa0809329
21. JT Hanlon CF Pieper ER Hajjar RJ Sloane CI Lindblad CM Ruby KE Schmader 2006 Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay J Gerontol A Biol Sci Med Sci 61 511 515 16720750 (Pubitemid 43794712)
22. AK Wittkowsky SJ Boccuzzi J Wogen G Wygant P Patel O Hauch 2004 Frequency of concurrent use of warfarin with potentially interacting drugs Pharmacotherapy 24 1668 1674 15585436 10.1592/phco.24.17.1668.52338 1:CAS:528:DC%2BD2MXhtlShuw%3D%3D (Pubitemid 39578956)